Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER2 Positive Early Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04436744
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

Who this might be right for
Early Breast Cancer
Hoffmann-La Roche 221
Testing effectiveness (Phase 2)Looking for participantsNCT07340398
What this trial is testing

Neoadjuvant Trastuzumab-rezetecan Plus Pertuzumab or Nab-Paclitaxel, Carboplatin, Trastuzumab, and Pyrotinib After Suboptimal Response to Neoadjuvant Dual HER2-Targeted Therapy Combined With Chemotherapy in HER2-Positive Early Breast Cancer

Who this might be right for
HER2-positive Early Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129187
What this trial is testing

SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response

Who this might be right for
Early Breast CancerHER2 + Breast CancerStage II Breast Cancer+1 more
Chuan Wang 30
Very early researchStudy completedNCT00949247
What this trial is testing

Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 20
Not applicableStudy completedNCT02521363
What this trial is testing

Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07428018
What this trial is testing

Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib

Who this might be right for
Breast CancerHER2 + Breast CancerHR Positive+1 more
Mario Negri Institute for Pharmacological Research 150
Not applicableNot Yet RecruitingNCT06718335
What this trial is testing

Pyrotinib in HER2-positive Early Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Nie Jianyun 156
Not applicableStudy completedNCT02658461
What this trial is testing

An Observational Time and Motion Study of Trastuzumab Subcutaneous (SC) and Intravenous (IV) Formulations in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (EBC)

Who this might be right for
Breast Cancer
Hoffmann-La Roche 36
Testing effectiveness (Phase 2)Study completedNCT01367028
What this trial is testing

A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer

Who this might be right for
Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 100
Not applicableLooking for participantsNCT06762977
What this trial is testing

A Composite Assay for HER2-positive Early-stage Breast Cancer Management

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)HER2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 180
Testing effectiveness (Phase 2)Looking for participantsNCT05834764
What this trial is testing

Pyrotinib in Women With High-risk in Early Stage Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 188
Testing effectiveness (Phase 2)Study completedNCT00545688
What this trial is testing

Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 417
Large-scale testing (Phase 3)Study completedNCT02187744
What this trial is testing

PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)

Who this might be right for
Early Breast Cancer
Pfizer 226
Large-scale testing (Phase 3)Active Not RecruitingNCT04055493
What this trial is testing

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

Who this might be right for
Breast Cancer Female
Women's Cancer Study Group GmbH 1,684
Large-scale testing (Phase 3)Active Not RecruitingNCT03701334
What this trial is testing

A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

Who this might be right for
Early Breast Cancer
Novartis Pharmaceuticals 5,101
Testing effectiveness (Phase 2)Active Not RecruitingNCT05710666
What this trial is testing

Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)

Who this might be right for
HER2-positive Breast Cancer
Cancer Trials Ireland 11
Testing effectiveness (Phase 2)Looking for participantsNCT04750122
What this trial is testing

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients

Who this might be right for
HER2-positive Early Breast Cancer
Peking University People's Hospital 46
Not applicableLooking for participantsNCT06723990
What this trial is testing

Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
European Institute of Oncology 60
Not applicableStudy completedNCT06907082
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neoadjuvant Treatment Based on Dual Blockade With Pertuzumab and the Trastuzumab Biosimilar CT-P6 (Herzuma®) in Early HER2-positive Breast Cancer in Routine Clinical Practice

Who this might be right for
Breast Cancer
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 106
Large-scale testing (Phase 3)Study completedNCT03989037
What this trial is testing

SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Early Breast Cancer
Shanghai Institute Of Biological Products 580
Next Page